GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Cyclically Adjusted PS Ratio

AbbVie (BSP:ABBV34) Cyclically Adjusted PS Ratio : 6.51 (As of Apr. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AbbVie Cyclically Adjusted PS Ratio?

As of today (2024-04-27), AbbVie's current share price is R$51.25. AbbVie's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was R$7.87. AbbVie's Cyclically Adjusted PS Ratio for today is 6.51.

The historical rank and industry rank for AbbVie's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:ABBV34' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.91   Med: 6.15   Max: 8.05
Current: 6.4

During the past years, AbbVie's highest Cyclically Adjusted PS Ratio was 8.05. The lowest was 4.91. And the median was 6.15.

BSP:ABBV34's Cyclically Adjusted PS Ratio is ranked worse than
87.23% of 736 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs BSP:ABBV34: 6.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AbbVie's adjusted revenue per share data for the three months ended in Dec. 2023 was R$2.466. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$7.87 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie Cyclically Adjusted PS Ratio Historical Data

The historical data trend for AbbVie's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Cyclically Adjusted PS Ratio Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 6.12 6.55 6.79 5.93

AbbVie Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.79 6.49 5.34 5.77 5.93

Competitive Comparison of AbbVie's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, AbbVie's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Cyclically Adjusted PS Ratio falls into.



AbbVie Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AbbVie's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=51.25/7.87
=6.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, AbbVie's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.466/129.4194*129.4194
=2.466

Current CPI (Dec. 2023) = 129.4194.

AbbVie Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.412 99.695 0.535
201406 0.428 100.560 0.551
201409 0.456 100.428 0.588
201412 0.558 99.070 0.729
201503 0.615 99.621 0.799
201506 0.652 100.684 0.838
201509 0.871 100.392 1.123
201512 0.945 99.792 1.226
201603 0.847 100.470 1.091
201606 0.846 101.688 1.077
201609 0.797 101.861 1.013
201612 0.877 101.863 1.114
201703 0.797 102.862 1.003
201706 0.894 103.349 1.120
201709 0.854 104.136 1.061
201712 0.992 104.011 1.234
201803 1.019 105.290 1.253
201806 1.241 106.317 1.511
201809 1.396 106.507 1.696
201812 1.343 105.998 1.640
201903 1.267 107.251 1.529
201906 1.340 108.070 1.605
201909 1.472 108.329 1.759
201912 1.502 108.420 1.793
202003 1.774 108.902 2.108
202006 2.053 108.767 2.443
202009 2.455 109.815 2.893
202012 2.502 109.897 2.946
202103 2.581 111.754 2.989
202106 2.470 114.631 2.789
202109 2.663 115.734 2.978
202112 2.956 117.630 3.252
202203 2.368 121.301 2.526
202206 2.590 125.017 2.681
202209 2.733 125.227 2.825
202212 2.783 125.222 2.876
202303 2.241 127.348 2.277
202306 2.375 128.729 2.388
202309 2.427 129.860 2.419
202312 2.466 129.419 2.466

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AbbVie  (BSP:ABBV34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AbbVie Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of AbbVie's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie (BSP:ABBV34) Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (BSP:ABBV34) Headlines

No Headlines